Sphera Funds Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Sphera Funds Management’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-323,348	Closed	-$2.85M	–	173
2021 Q1	$2.85M	Sell	323,348 -144,314	-31%	-$1.58M	0.22%	96
2020 Q4	$4.78M	Sell	467,662 -1,583	-0.3%	-$17.3K	0.42%	68
2020 Q3	$4.24M	Hold	469,245	–	–	0.42%	64
2020 Q2	$3.35M	Sell	469,245 -6,432	-1%	-$68.3K	0.32%	61
2020 Q1	$4.52M	Buy	475,677 +4,238	+0.9%	+$54.6K	0.57%	39
2019 Q4	$6.2M	Buy	+471,439	New	+$5.75M	0.51%	44

Other funds holding GRTX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management's GRTX Position: Q2 2021 in Review

Sphera Funds Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2021, closing a stake of 323,348 shares — an estimated $2.85M sold.

Sphera Funds Management first reported a position in GRTX in Q4 2019 and held it in 6 quarters. The position peaked at $6.2M in Q4 2019. 47 funds tracked by Wall St. Rank hold GRTX as of Q2 2021.

Sphera Funds Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Sphera Funds Management sold 323,348 Galera Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $2.85M.
Sphera Funds Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Sphera Funds Management's Galera Therapeutics, Inc. Common Stock position peaked at $6.2M in Q4 2019.
47 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Sphera Funds Management's 13F filing for Q2 2021, filed 17 Aug 2021.